Join us as we congratulate the principal investigators listed below who received a new or competitive renewal award in 2009.
American Recovery and Reinvestment Act (ARRA) of 2009
View the ARRA Supplement Awards as of September 30, 2009.
Sponsored Projects - September 2009
Tim A. Ahles, PhD, Psychiatry/Neuropsychiatry
- Project Title: The CCNY/MSKCC Partnership for Research Training and Outreach
- Total Direct Cost: $176,209
- Award Date: 9/16/09
- Project Duration: 1 Year
- Awarding Agency: National Cancer Institute
Ethan Martin Basch, MD, Epidemiology & Biostatistics
- Project Title: Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
- Total Direct Cost: $92,585
- Award Date: 9/15/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Sarat Chandarlapaty, MD, Breast Cancer Medicine
- Project Title: Biologic and Therapeutic Implications of AKT activation in HER2+ Breast Cancer
- Total Direct Cost: $672,000
- Award Date: 9/21/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute
Bo Dupont, MD, Immunology
- Project Title: Hematopoeitic Stem Cell Transplantation
- Total Direct Cost: $46,047
- Award Date: 9/21/09
- Project Duration: 1 Year
- Awarding Agency: Fred Hutchinson Cancer Research Center/National Institute of Allergy and Infectious Diseases
James Eastham, MD, Urology
- Project Title: Comparative Analysis of Surgical Treatment Options for Localized Prostate Cancer
- Total Direct Cost: $354,702
- Award Date: 9/30/09
- Project Duration: 2 Years
- Awarding Agency: National Institutes of Health
Sacha Gnjatic, PhD, Immunology
- Project Title: Seromics; Discovery and Validation of Novel Targets and Markers for Cancer Therapy and Diagnosis
- Total Direct Cost: $403,762
- Award Date: 9/01/09
- Project Duration: 1 Year
- Awarding Agency: Cancer Research Institute
Udayan Guha, MD, Medicine
- Project Title: Mutant Epidermal Growth Factor Receptor Signaling in Lung Cancer
- Total Direct Cost: $306,490
- Award Date: 9/09/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Eric Holland, MD, Neurosurgery/Cancer Biology and Genetics
- Project Title: Tumor Microenvironment Interactions in Brain Tumors
- Total Direct Cost: $200,000
- Award Date: 9/01/09
- Project Duration: 1 Year
- Awarding Agency: National Cancer Institute
Hedvig Hricak, MD, PhD, Radiology/Molecular Pharmacology & Chemistry
- Project Title: Molecular Imaging: Training for Oncology
- Total Direct Cost: $2,499,277
- Award Date: 9/22/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute
Xuejun Jiang, PhD, Cell Biology
- Project Title: Identification of Inhibitory Compounds for Apaf-1 by High Throughput Screening
- Total Direct Cost: $415,000
- Award Date: 9/18/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Andrew C. Koff, PhD, Molecular Biology
- Project Title: CDK Inhibitors in Tumor Progression
- Total Direct Cost: $200,000
- Award Date: 9/01/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Marc Ladanyi, MD, Surgical Pathology
- Project Title: The TCGA Cancer Genome Characterization Center at Memorial Sloan-Kettering Cancer Center
- Total Direct Cost: $280,000
- Award Date: 9/01/09
- Project Duration: 1 Year
- Awarding Agency: National Cancer Institute
Wendy G. Lichtenthal, PhD, Psychiatry & Behavioral Sciences
- Project Title: Themes of Meaning: Intervention Development for Parents Bereaved by Cancer
- Total Direct Cost: $100,000
- Award Date: 9/01/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Gikas S. Mageras, PhD, Medical Physics
- Project Title: Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver
- Total Direct Cost: $249,864
- Award Date: 9/01/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Matthew I. Milowsky, MD, Genitourinary Oncology
- Project Title: Bladder Cancer Oncogenome
- Total Direct Cost: $112,500
- Award Date: 9/01/09
- Project Duration: 2 Years
- Awarding Agency: American Association for Cancer Research
Kevin Oeffinger, MD, Pediatrics
- Project Title: EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
- Total Direct Cost: $2,422,263
- Award Date: 9/23/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute
Antonio M. Omuro, MD, Neurology
- Project Title: A phase I/IITrial of Temozolomide and ABT-888 in Subjects with Newly Diagnosed Glioblastoma Multiforme
- Total Direct Cost: $111,110
- Award Date: 9/01/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute/Johns Hopkins University
Jamie Ostroff, PhD, Psychiatry
- Project Title: Psychosocial Palliative and Community Research in Cancer
- Total Direct Cost: $2,471,760
- Award Date: 9/21/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute
Christine A. Pratilas, MD, Pediatrics
- Project Title: Feedback Regulation and Functional Output of the RAF-MEK-ERK Signaling Pathway
- Total Direct Cost: $802,000
- Award Date: 9/21/09
- Project Duration: 5 Years
- Awarding Agency: National Cancer Institute
Andrea Pusic, MD, MHS, Plastic and Reconstructive Service
- Project Title: A New Patient-Reported Outcome Measure for Body Contouring
- Total Direct Cost: $50,000
- Award Date: 9/28/09
- Project Duration: 1 Year
- Awarding Agency: Plastic Surgery Educational Foundation
Emily J. Quann, PhD, Immunology
- Project Title: Mechanistic Analysis of T Cell MTOC Reorientation with a Photoactivatable Antigen
- Total Direct Cost: $99,664
- Award Date: 9/30/09
- Project Duration: 2 Years
- Awarding Agency: National Institute of Allergy and Infectious Diseases
Derek B. Sant'Angelo, PhD, Immunology
- Project Title: The Function of the NKT Cell Determinant, PLZF, in the Mucosal Lymphocytes
- Total Direct Cost: $275,000
- Award Date: 9/03/09
- Project Duration: 2 Years
- Awarding Agency: National Institute of Allergy and Infectious Diseases
Charles Sawyers, MD, Human Oncology & Pathogenesis Program (HOPP)
- Project Title: New Insights from old Cancer Targets: Kinases and Nuclear Receptors
- Total Direct Cost: $85,000
- Award Date: 9/15/09
- Project Duration: 1 Year
- Awarding Agency: American Association for Cancer Research
Charles Sawyers, MD, Human Oncology & Pathogenesis Program (HOPP)
- Project Title: IND Enabling Toxicology Studies of the Antiandrogen A52 for Treatment of Hormone Refractory (Castration-Resistant) Prostate Cancer (CRPC)
- Total Direct Cost: $500,000
- Award Date: 9/28/09
- Project Duration: 1 Year
- Awarding Agency: Technology Development Fund
David Scheinberg, MD, PhD, Medicine/Leukemia/Molecular Pharmacology & Chemistry
- Project Title: Drug Manufacturing and Conduct of a Phase 2 Trial of a WT1 Vaccine Broadly Active Against Multiple Cancers
- Total Direct Cost: $500,000
- Award Date: 9/28/09
- Project Duration: 3 Years
- Awarding Agency: Technology Development Fund
Howard Scher, MD, Genitourinary Oncology Service
- Project Title: Coordinating Center Application for Prostate Cancer Research Program Clinical Consortium Award
- Total Direct Cost: $10,929,910
- Award Date: 9/01/09
- Project Duration: 5 Years
- Awarding Agency: Congressionally Directed Medical Research Programs/DOD - Department of Defense
Susan Slovin, MD, PhD, Genitourinary Oncology Service
- Project Title: Clinical Investigation of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer
- Total Direct Cost: $750,000
- Award Date: 9/28/09
- Project Duration: 3 Years
- Awarding Agency: Congressionally Directed Medical Research Programs/DOD - Department of Defense
David R. Spriggs, MD, Medical Oncology Service
- Project Title: Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
- Total Direct Cost: $378,599
- Award Date: 9/17/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Lorenz Studer, MD, Neurosurgery/Developmental Biology
- Project Title: Defining Fate Potential in hESC Derived Neural Stem Cells
- Total Direct Cost: $542,166
- Award Date: 9/07/09
- Project Duration: 2 Years
- Awarding Agency: National Institute of Neurological Disorders and Stroke
Paul J. Tempst, PhD, Molecular Biology
- Project Title: Assessment of Serum Peptide Profiling to Detect Cancer-Specific Patterns
- Total Direct Cost: $183,871
- Award Date: 9/15/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Harold Varmus, MD, Medicine/Cancer Biology & Genetics
- Project Title: Cancer Center Support Grant
- Total Direct Cost: $52,510
- Award Date: 9/04/09
- Project Duration: 11 Months
- Awarding Agency: National Cancer Institute
Harold Varmus, MD, Medicine/Cancer Biology & Genetics
- Project Title: Cancer Center Support Grant
- Total Direct Cost: $294,806
- Award Date: 9/21/09
- Project Duration: 4 Years
- Awarding Agency: National Cancer Institute
Harold Varmus, MD, Medicine/Cancer Biology & Genetics
- Project Title: Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice
- Total Direct Cost: $215,019
- Award Date: 9/24/09
- Project Duration: 1 Year
- Awarding Agency: National Cancer Institute
Brian Zeglis, BS, Radiology
- Project Title: PET Imaging of Topoisomerase-II Expression in Breast Cancer
- Total Direct Cost: $142,482
- Award Date: 9/25/09
- Project Duration: 3 Years
- Awarding Agency: National Cancer Institute
Industrial Affairs - September 2009
Juliet N. Barker, MBBS, Bone Marrow Transplant Service
- Project Title: A Non-Myeloablative Conditioning Regiment with Peri- Transplant Rituximab and Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B Cell Lymphoid Malignancies
- Total Direct Cost: $5,500
- Award Date: 9/24/09
- Awarding Agency: Genentech, Inc.
Oren J. Becher, MD, Pediatrics
- Project Title: Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors
- Total Direct Cost: $160,703.56
- Award Date: 9/04/09
- Awarding Agency: National Comprehensive Cancer Network
Hugo Castro-Malaspina, MD, Bone Marrow Transplant Service
- Project Title: A Non-Myeloablative Conditioning Regiment with Peri-Transplant Rituximab and Transplantation of Matched Related or Unrelated Volunteer Donor Hematopoietic Stem Cells (HSC) in Patients with B Cell Lymphoid Malignancies
- Total Direct Cost: $5,500
- Award Date: 9/24/09
- Awarding Agency: Genentech, Inc.
Michael Morris, MD, Genitourinary Oncology Service
- Project Title: A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined with Dasatinib to Docetaxel Combined with Placebo in Castration-Resistant Prostate Cancer
- Total Direct Cost: $120,167
- Award Date: 9/01/09
- Awarding Agency: Bristol-Myers Squibb
Sponsored Projects - August 2009
Carol A. Aghajanian, MD, Gynecologic Medical Oncology
- Project Title: Gynecologic Oncology Group DTM0834
- Total Direct Cost: $52,789
- Award Date: 8/6/09
- Project Duration: 1 Year
- Awarding Agency: Gynecological Oncology Group/National Cancer Institute
Brett S. Carver, MD, Urology Service
- Project Title: The Role of PHLPP Phosphatases in PTEN Mutant Prostate Cancer Progression
- Total Direct Cost: $250,000
- Award Date: 8/3/09
- Project Duration: 2 Years
- Awarding Agency: Starr Cancer Consortium
Timothy Chan, MD, PhD, Radiation Therapy
- Project Title: Identification of microRNAs that Predict Metastatic Relapse and Sensitivity to Chemotherapy in Human Colorectal Cancer
- Total Direct Cost: $500,000
- Award Date: 8/3/09
- Project Duration: 2 Years
- Awarding Agency: Starr Cancer Consortium
Katherine DuHamel, PhD, Psychiatry & Behavioral Sciences
- Project Title: Increasing the Sexual Health of Male Rectal Cancer Patients: A Pilot Study
- Total Direct Cost: $242,000
- Award Date: 8/1/09
- Project Duration: 2 Years
- Awarding Agency: National Cancer Institute
Adriana Haimovitz-Friedman, PhD, Radiation Oncology
- Project Title: Consortium Agreement - Anne Davidson
- Total Direct Cost: $30,000
- Award Date: 8/27/09
- Project Duration: 11 Months
- Awarding Agency: Feinstein Institute for Medical Research
Douglas A. Levine, MD, Gynecology Service
- Project Title: Integrated Genetic Analysis of Epithelial Ovarian Cancer
- Total Direct Cost: $346,614
- Award Date: 8/3/09
- Project Duration: 2 Years
- Awarding Agency: Starr Cancer Consortium
Harold Varmus, MD, Medicine/Cancer Biology & Genetics
- Project Title: Cancer Center Support Grant
- Total Direct Cost: $51,842
- Award Date: 8/29/09
- Project Duration: 23 Months
- Awarding Agency: National Cancer Institute
Industrial Affairs - August 2009
Eileen O'Reilly, MD, Solid Tumor
- Project Title: A Global, Multi Center, Open Label Phase 2 Study of AGS-1C4D4 Given in Combination with Gemcitabine in Subjects with Metastatic Pancreatic Cancer
- Total Direct Cost: $147,688
- Award Date: 8/26/09
- Awarding Agency: Agensys Inc.
Gregory J. Riely, MD, PhD, Solid Tumor Thoracic
- Project Title: A Randomized Discontinuation Phase II Trial of Deforolimus in Non-Small Cell Lung Cancer (NSCLC) In Patients with KRAS Mutations
- Total Direct Cost: $233,524
- Award Date: 8/26/09
- Awarding Agency: Merck & Co
Neal Rosen, MD, PhD, Medicine/Breast Cancer Medicine/Molecular Pharmacology & Chemistry Program
- Project Title: Extended Project 18 (AZD 8155) AZ4 AZ5
- Total Direct Cost: $150,000
- Award Date: 8/5/09
- Awarding Agency: AstraZeneca
|
